PBLA Chart
- 52-Week Range: $1.43 - $92.40
- Market Capitalization: $1.80M
- Short Percentage: 0%
- Target Price: $380.00
- Shares Outstanding: 1.18M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
PBLA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Panbela Announces Pricing of Approximately $15 Million Public OfferingGlobeNewsWire | January 26th
- Panbela Announces 1-for-40 Reverse Stock Split effective January 13, 2023GlobeNewsWire | January 12th
- Panbela Provides Business Update and Reports Q3 2022 Financial ResultsGlobeNewsWire | November 10th
- Panbela Schedules Conference Call on, November 10, 2022, to Report 2022 Third Quarter Financial ResultsGlobeNewsWire | October 31st
- Panbela to Participate in the Roth Inaugural Healthcare Opportunities ConferenceGlobeNewsWire | October 6th
- Panbela Announces Pricing of Approximately $6 Million Public OfferingGlobeNewsWire | September 30th
- Panbela Therapeutics, Inc.'s (PBLA) CEO Jennifer Simpson on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha | August 15th
- Panbela Provides Business Update and Reports Q2 2022 Financial ResultsGlobeNewsWire | August 15th
Company Info
Website: https://www.panbela.com
Address: 712 Vista Boulevard, Waconia, MN, United States, 55387
Sector: Healthcare
Industry: Biotechnology
Full time employees: 4
Address: 712 Vista Boulevard, Waconia, MN, United States, 55387
Sector: Healthcare
Industry: Biotechnology
Full time employees: 4
$PBLA has just been halted from trading due to volatility.
$PBLA Same thing
different day
$PBLA has just been halted from trading due to volatility.
$PBLA has just been halted from trading due to volatility.
$PBLA has just been halted from trading due to volatility.
$PBLA NOT SELLING.
$PBLA has just been halted from trading due to volatility.
$PBLA i'm out of slaps for the day
$PBLA News?
$PBLA has just been halted from trading.